Titlebook: Hot Topics in Infection and Immunity in Children II; Andrew J. Pollard,Adam Finn Conference proceedings 2005 The Editor(s) (if applicable)

火車車輪

BOON

Dexamethasone in the Treatment of Pediatric Bacterial Meningitis in Developing Countries: Is it Benn resource constrained countries is 10 times that of developed countries, the mortality is 12–50% compared with less than 5% and sequelae are under-reported and probably greatly exceed the 15–20% reported from the West (Cadoz et al., 1991; Salih et al., 1991; Tefaurini and Vince., 1992; Carroll and

FLAG

Should Dexamethasone be Part of Routine Therapy of Bacterial Meningitis in Industrialised Countriesial in 2004. There was minimal evidence of reduction in mortality or severe sequelae in early trials. (2) Interest was rekindled following the publication of results of two trials conducted in Dallas by Dr George McCracken and colleagues, which demonstrated for the first time a reduction in hearing

經(jīng)典

Reverse Vaccinology and Vaccines for Serogroup B ,creening of genome data for surface-expressed proteins, in order to identify candidate vaccine antigens. . confirmation of surface location and the use of animal models to test immunogenicity further refine the list of proteins likely to be of useas vaccine antigens. This process, first applied to s

嚴(yán)峻考驗

談判

chassis

Alopecia-Areata

nocturnal

邊緣帶來墨水